10 research outputs found
Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients
Full text linkStatin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study
Get PDFStatin Use Is Not Associated with Improved Progression Free Survival in Cetuximab Treated KRAS Mutant Metastatic Colorectal Cancer Patients: Results from the CAIRO2 Study
No full textImmunohistochemical analysis of K-RAS expression in curatively treated colorectal cancer patients: Correlations of clinicopathological features with clinical outcome
No full textKRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines
No full textA randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
No full text
